PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32386503-4	2021	RESULTS: The results demonstrated that the neuropharmacological activities of beta-CBP may involve benzodiazepine/GABAergic receptors, since the pre-treatment of beta-CBP (200 mg/kg) associated with flumazenil (5 mg/kg, benzodiazepine receptor antagonist) and bicuculline (1 mg/kg, selective GABAA receptor antagonist) reestablished the anxiety parameters in the elevated plus-maze test, as well as the results of reduced latency to consume food in the novelty suppressed feeding test.	Flumazenil	199-209	CREB binding protein	Mus musculus	83-86	
32386503-4	2021	RESULTS: The results demonstrated that the neuropharmacological activities of beta-CBP may involve benzodiazepine/GABAergic receptors, since the pre-treatment of beta-CBP (200 mg/kg) associated with flumazenil (5 mg/kg, benzodiazepine receptor antagonist) and bicuculline (1 mg/kg, selective GABAA receptor antagonist) reestablished the anxiety parameters in the elevated plus-maze test, as well as the results of reduced latency to consume food in the novelty suppressed feeding test.	Flumazenil	199-209	CREB binding protein	Mus musculus	167-170